HEALTH (ALT)

Treatments for DCIS can cause cancer

(NaturalNews) According to the Journal of the National Cancer Institute, DCIS is “Ductal Cell Carcinoma in Situ”, a condition of abnormal, non-cancerous cells found in the milk ducts which have not spread to nearby tissues. It is often referred to as a “pre-cancer” condition, according…

Treatments for DCIS can cause cancer

(NaturalNews) According to the Journal of the National Cancer Institute, DCIS is “Ductal Cell Carcinoma in Situ”, a condition of abnormal, non-cancerous cells found in the milk ducts which have not spread to nearby tissues. It is often referred to as a “pre-cancer” condition, according…

KWN HEALTH

HEALTH (MSM)

Exclusive: Hospira wins French biosimilar drug tender at 45 percent discount

By Matthias Blamont PARIS (Reuters) – A major French hospital group has chosen a cheap copycat version of a top-selling drug for treating its patients with rheumatoid arthritis, Crohn’s disease and psoriasis in a victory for a new type of medicine known as biosimilars.    In a document seen by Reuters, the central purchasing agency for the Assistance Publique – Hôpitaux de Paris (AP-HP) said on Friday it had decided to

U.N. calls on Israel, Palestinians to prosecute Gaza war crimes

By Stephanie Nebehay GENEVA (Reuters) – The United Nations called on Israel and the Palestinians on Friday to prosecute alleged war crimes committed in the 2014 Gaza war and to cooperate with the International Criminal Court’s preliminary investigation. The 47-member U.N. Human Rights Council adopted a resolution, presented by Muslim states, by a vote of 41 to one, with five abstentions. Israel’s closest ally, the United States, was the only

Hospira wins French biosimilar drug tender at 45 percent discount

PARIS (Reuters) – A major French hospital group has chosen a cheap copycat version of a top-selling drug for treating its patients with rheumatoid arthritis and Crohn’s disease in a victory for a new type of medicine known as biosimilars.    In a document seen by Reuters, the central purchasing agency for the Assistance Publique – Hôpitaux de Paris (AP-HP) said on Friday it had decided to buy the biosimilar version